Gamelin Erick
SEC insider (Form 3/4/5 filer). CIK 0001950551. Chief Development Officer at Acrivon Therapeutics, Inc. (ACRV). 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WATERTOWN, MA.
Companies Gamelin Erick has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Officer, Chief Development Officer
Gamelin Erick
CIK: 0001950551
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Acrivon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect400 shares at avg. $2.01$804 - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect38.6K shares- - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect404 shares at avg. $1.92$775.68 - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
94.9K shares- - Feb 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect471 shares at avg. $1.63$767.73 - Nov 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect403 shares at avg. $2.24$902.72 - Aug 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect403 shares at avg. $1.39$560.17 - May 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect403 shares at avg. $1.14$459.42 - Mar 1, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
78.1K shares- - Feb 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect469 shares at avg. $5.42$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 400 | $2.01 | $804 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 38,584 | - | $0 | Direct |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 404 | $1.92 | $776 | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 94,946 | - | - | Direct |
| Feb 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 471 | $1.63 | $768 | Direct |
| Nov 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 403 | $2.24 | $903 | Direct |
| Aug 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 403 | $1.39 | $560 | Direct |
| May 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 403 | $1.14 | $459 | Direct |
| Mar 1, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 78,078 | - | - | Direct |
| Feb 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 469 | $5.42 | $2,542 | Direct |
1-10 of 12 transactions